Citations

Citations to this article as recorded by  

• Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
  Jee Hee Yoo, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2023; 47(1): 27.     CrossRef
• Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experience
  Judith Nir, Marianna Rachmiel, Abigail Fraser, Yael Lebenthal, Avivit Brener, Orit Pinhas-Hamiel, Alon Haim, Eve Stern, Noa Levek, Tal Ben-Ari, Zohar Landau
  Endocrine.2023; 81(2): 262.     CrossRef
• Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial
  Mengyun Lei, Beisi Lin, Ping Ling, Zhigu Liu, Daizhi Yang, Hongrong Deng, Xubin Yang, Jing Lv, Wen Xu, Jinhua Yan
  BMJ Open.2023; 13(8): e073263.     CrossRef
• Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey
  Antonia Huhndt, Yanbing Chen, Shane O’Donnell, Drew Cooper, Hanne Ballhausen, Katarzyna A. Gajewska, Timothée Froment, Mandy Wäldchen, Dana M. Lewis, Klemens Raile, Timothy C. Skinner, Katarina Braune
  Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
• Toward Personalized Hemoglobin A1c Estimation for Type 2 Diabetes
  Namho Kim, Da Young Lee, Wonju Seo, Nan Hee Kim, Sung-Min Park
  IEEE Sensors Journal.2022; 22(23): 23023.     CrossRef

Citations

Citations to this article as recorded by  

• Integration of a Safety Module to Prevent Rebound Hypoglycemia in Closed-Loop Artificial Pancreas Systems
  María F. Villa-Tamayo, Patricio Colmegna, Marc D. Breton
  Journal of Diabetes Science and Technology.2024; 18(2): 318.     CrossRef
• A new approach to stabilize diabetes systems with time-varying delays and disturbance rejection
  S. Syafiie, Fahd Alharbi, Abdullah Ali Alshehri, Bassam Hasanain
  Journal of the Franklin Institute.2024; 361(1): 543.     CrossRef
• Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs
  Ingrid Anna Teigen, Marte Kierulf Åm, Misbah Riaz, Sverre Christian Christiansen, Sven Magnus Carlsen
  Current Therapeutic Research.2024; 100: 100736.     CrossRef
• Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes
  John Pemberton, Louise Collins, Lesley Drummond, Renuka P Dias, Ruth Krone, Melanie Kershaw, Suma Uday
  BMJ Open Diabetes Research & Care.2024; 12(3): e004045.     CrossRef
• Robust Online Correlation Method for Identification of a Nonparametric Model of Type 1 Diabetes
  Martin Dodek, Eva Miklovičová
  IEEE Access.2024; 12: 35899.     CrossRef
• Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
  Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim
  Diabetologia.2024; 67(7): 1235.     CrossRef
• Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways
  Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Maria Luisa Garo, Donatella Pastore, Francesca Pacifici, Camillo Ricordi, David Della-Morte, Marco Infante
  Metabolism and Target Organ Damage.2024;[Epub]     CrossRef
• Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions
  Giulia Bennici, Hanan Almahasheer, Mawadda Alghrably, Daniela Valensin, Arian Kola, Chrysoula Kokotidou, Joanna Lachowicz, Mariusz Jaremko
  RSC Advances.2024; 14(25): 17448.     CrossRef
• Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
  Qin Yang, Baoqi Zeng, Jiayi Hao, Qingqing Yang, Feng Sun
  Diabetes, Obesity and Metabolism.2024; 26(9): 3753.     CrossRef
• Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study
  Marta Bassi, Daniele Franzone, Francesca Dufour, Giordano Spacco, Federico Cresta, Giuseppe d’Annunzio, Giacomo Tantari, Maria Grazia Calevo, Carlo Castellani, Nicola Minuto, Rosaria Casciaro
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Emerging Technologies in Endocrine Drug Delivery: Innovations for Improved Patient Care
  Mahvish Renzu, Carly Hubers, Kendall Conway, Viktoriya Gibatova, Vidhi Mehta, Wael Taha
  Cureus.2024;[Epub]     CrossRef
• A stochastic model-based control methodology for glycemic management in the intensive care unit
  Melike Sirlanci, George Hripcsak, Cecilia C. Low Wang, J. N. Stroh, Yanran Wang, Tellen D. Bennett, Andrew M. Stuart, David J. Albers
  Frontiers in Medical Engineering.2024;[Epub]     CrossRef
• Advances in Type 1 Diabetes Mellitus Management in Children
  Mridu Bahal, Vineeta Pande, Jasleen Dua, Shailaja Mane
  Cureus.2024;[Epub]     CrossRef
• 100 Years of insulin: A chemical engineering perspective
  B. Wayne Bequette
  Korean Journal of Chemical Engineering.2023; 40(1): 1.     CrossRef
• Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial
  Sun Joon Moon, Kyung‐Soo Kim, Woo Je Lee, Mi Yeon Lee, Robert Vigersky, Cheol‐Young Park
  Diabetes, Obesity and Metabolism.2023; 25(1): 110.     CrossRef
• Identifiable prediction animal model for the bi-hormonal intraperitoneal artificial pancreas
  Karim Davari Benam, Hasti Khoshamadi, Marte Kierulf Åm, Øyvind Stavdahl, Sebastien Gros, Anders Lyngvi Fougner
  Journal of Process Control.2023; 121: 13.     CrossRef
• Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
  Jee Hee Yoo, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2023; 47(1): 27.     CrossRef
• CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review
  John S Pemberton, Emma G Wilmot, Katharine Barnard‐Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
  Diabetes, Obesity and Metabolism.2023; 25(4): 916.     CrossRef
• Evaluation of awareness and attitude of paediatric nursing students, nurses, and adolescents regarding type one diabetes advanced devices and virtual nursing
  Howaida Moawad Ahmed Ali
  Kontakt.2023; 25(2): 100.     CrossRef
• Predicting the output error of the suboptimal state estimator to improve the performance of the MPC-based artificial pancreas
  Martin Dodek, Eva Miklovičová
  Control Theory and Technology.2023; 21(4): 541.     CrossRef
• A Markov Model of Gap Occurrence in Continuous Glucose Monitoring Data for Realistic in Silico Clinical Trials
  Martina Vettoretti, Martina Drecogna, Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino
  Computer Methods and Programs in Biomedicine.2023; 240: 107700.     CrossRef
• Drug delivery breakthrough technologies – A perspective on clinical and societal impact
  Beate Bittner, Manuel Sánchez-Félix, Dennis Lee, Athanas Koynov, Joshua Horvath, Felix Schumacher, Simon Matoori
  Journal of Controlled Release.2023; 360: 335.     CrossRef
• Importance of continuous glucose monitoring in the treatment of diabetes mellitus
  Sun Joon Moon, Won-Young Lee
  Journal of the Korean Medical Association.2023; 66(7): 432.     CrossRef
• Constrained Versus Unconstrained Model Predictive Control for Artificial Pancreas
  Chiara Toffanin, Lalo Magni
  IEEE Transactions on Control Systems Technology.2023; 31(5): 2288.     CrossRef
• Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
  Valentina Maria Cambuli, Marco Giorgio Baroni
  International Journal of Molecular Sciences.2023; 24(17): 13139.     CrossRef
• Artificial Intelligence in Efficient Diabetes Care
  Gopal Bhagwan Khodve, Sugato Banerjee
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control
  M. K. Åm, I. A. Teigen, M. Riaz, A. L. Fougner, S. C. Christiansen, S. M. Carlsen
  Journal of Endocrinological Investigation.2023;[Epub]     CrossRef
• Multivariable Automated Insulin Delivery System for Handling Planned and Spontaneous Physical Activities
  Mohammad Reza Askari, Mohammad Ahmadasas, Andrew Shahidehpour, Mudassir Rashid, Laurie Quinn, Minsun Park, Ali Cinar
  Journal of Diabetes Science and Technology.2023; 17(6): 1456.     CrossRef
• Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences
  Maria Grazia Nuzzo, Marciano Schettino
  Diabetology.2023; 4(4): 519.     CrossRef
• The effects of acute hyperglycaemia on sports and exercise performance in type 1 diabetes: A systematic review and meta-analysis
  Bonar McGuire, Hashim Dadah, Dominic Oliver
  Journal of Science and Medicine in Sport.2023;[Epub]     CrossRef
• Artificial Pancreas under a Zone Model Predictive Control based on Gaussian Process models: toward the personalization of the closed loop
  Marco Polver, Beatrice Sonzogni, Mirko Mazzoleni, Fabio Previdi, Antonio Ferramosca
  IFAC-PapersOnLine.2023; 56(2): 9642.     CrossRef
• Personalized Constrained MPC for glucose regulation
  Chiara Toffanin, Lalo Magni
  IFAC-PapersOnLine.2023; 56(2): 9648.     CrossRef
• Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials
  Baoqi Zeng, Le Gao, Qingqing Yang, Hao Jia, Feng Sun
  Diabetes Care.2023; 46(12): 2300.     CrossRef
• Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
  Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis
  Baoqi Zeng, Hao Jia, Le Gao, Qingqing Yang, Kai Yu, Feng Sun
  Diabetes, Obesity and Metabolism.2022; 24(10): 1967.     CrossRef
• Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Systematic Review
  Alezandra Torres-Castaño, Amado Rivero-Santana, Lilisbeth Perestelo-Pérez, Andrea Duarte-Díaz, Analia Abt-Sacks, Vanesa Ramos-García, Yolanda Álvarez-Pérez, Ana M. Wäagner, Mercedes Rigla, Pedro Serrano-Aguilar
  Applied Sciences.2022; 12(20): 10262.     CrossRef
• History of insulin treatment of pediatric patients with diabetes in Korea
  Jae Hyun Kim, Choong Ho Shin, Sei Won Yang
  Annals of Pediatric Endocrinology & Metabolism.2021; 26(4): 237.     CrossRef